516 related articles for article (PubMed ID: 14561260)
41. The effects of analytical factors on second trimester risk estimations.
Serdar MA; Tütüncü L; Olgun A; Haşimi A; Ozgurtaş T; Erbil MK
Int J Gynaecol Obstet; 2006 Apr; 93(1):28-32. PubMed ID: 16530198
[TBL] [Abstract][Full Text] [Related]
42. Free beta human choriogonadotropin in Down's syndrome screening: a multicentre study of its role compared with other biochemical markers.
Spencer K; Coombes EJ; Mallard AS; Ward AM
Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():506-18. PubMed ID: 1280026
[TBL] [Abstract][Full Text] [Related]
43. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
44. Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
Ying I; Wyatt PR; Nisenbaum R; Ray JG
J Obstet Gynaecol Can; 2011 Dec; 33(12):1218-1222. PubMed ID: 22166275
[TBL] [Abstract][Full Text] [Related]
45. [Study on key techniques and intervention in reducing birth defects].
Zhu BS; Su J; Lu XH; He J; Zhu S; Jiao CX; Zhang JM; Tang XH; Tao Y; Lin KP; Chen H; Li SY
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):658-63. PubMed ID: 22176989
[TBL] [Abstract][Full Text] [Related]
46. Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.
Wenstrom KD; Desai R; Owen J; DuBard MB; Boots L
Am J Obstet Gynecol; 1995 Oct; 173(4):1287-92. PubMed ID: 7485339
[TBL] [Abstract][Full Text] [Related]
47. Antenatal screening for Down's syndrome.
Wald NJ; Kennard A; Hackshaw A; McGuire A
J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
[TBL] [Abstract][Full Text] [Related]
48. Maternal serum markers for Down's syndrome pregnancies.
Chew S; Anandakumar C; Ratnam SS
Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
[TBL] [Abstract][Full Text] [Related]
49. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
[TBL] [Abstract][Full Text] [Related]
50. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
51. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
52. Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.
Spencer K; Carpenter P
BMJ; 1993 Sep; 307(6907):764-9. PubMed ID: 7693095
[TBL] [Abstract][Full Text] [Related]
53. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
Qi QW; Jiang YL; Liu JT; Bian XM; Li Y; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Cai Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538
[TBL] [Abstract][Full Text] [Related]
54. Prospective audit of a one-centre combined nuchal translucency and triple test programme for the detection of trisomy 21.
Babbur V; Lees CC; Goodburn SF; Morris N; Breeze AC; Hackett GA
Prenat Diagn; 2005 Jun; 25(6):465-9. PubMed ID: 15966036
[TBL] [Abstract][Full Text] [Related]
55. Maternal serum screening.
Carroll JC
Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
[TBL] [Abstract][Full Text] [Related]
56. Participation in maternal serum screening following screen positive results in a previous pregnancy.
Rausch DN; Lambert-Messerlian GM; Canick JA
J Med Screen; 2000; 7(1):4-6. PubMed ID: 10807139
[TBL] [Abstract][Full Text] [Related]
57. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
58. Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study.
Mancini G; Perona M; Dall'Amico D; Bollati C; Albano F; Mazzone R; Rosso M; Grosso E; Migone N; Fiocchi F
Int J Clin Lab Res; 1994; 24(1):49-53. PubMed ID: 7514056
[TBL] [Abstract][Full Text] [Related]
59. The advantages of using triple-marker screening for chromosomal abnormalities.
Kellner LH; Weiss RR; Weiner Z; Neuer M; Martin GM; Schulman H; Lipper S
Am J Obstet Gynecol; 1995 Mar; 172(3):831-6. PubMed ID: 7534448
[TBL] [Abstract][Full Text] [Related]
60. [Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].
Bian XM; Liu JT; Qi QW; Jiang YL; Li Y; Liu SY; Hao N; Zhou J; Lü SM; Zhu BS; Wang H; Xu ZF; Pan XY; Liao C; Cai Y; Wang H; Wang Z; Zhu J; Hu YL
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):805-9. PubMed ID: 19087560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
